article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

‘Hot mess’: Abortion pills at pharmacies could face legal quagmires, especially in restrictive states

STAT News

WASHINGTON — Federal regulators’ green light for pharmacists to dispense abortion pills is crashing into legal questions and simmering court battles. The Food and Drug Administration earlier this month removed a longtime restriction that only doctors could dispense mifepristone, which is approved for abortions up to 10 weeks.

Pharmacy 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

article thumbnail

U.S. Pharmacy Chains Harm Patients With Medication Errors; NABP Appears Silent

Pharmacy Checkers

When you go to your local CVS and Walgreens – and other big pharmacy chains – are you getting the highest standard of care? Have these pharmacies gone rogue? Yet the National Association of Boards of Pharmacy (NABP) doesn’t seem to be paying much attention to medication errors at U.S. pharmacies. pharmacy industry.

article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . The new initiative, Care Studio, aims at doctors rather than patients. If pharmacies try to fill those generic prescriptions, the claims are rejected. Google is also giving health records another whirl.

Pharmacy 227
article thumbnail

DEA Proposes to Permit the Electronic Transfer of Initial Electronic Prescriptions for Schedules II-V Controlled Substances: Comment Period Ends January 18, 2022

FDA Law Blog

Palmer — DEA is proposing to amend its regulations to expressly permit the transfer between pharmacies of an initial controlled substance prescription. Currently, DEA regulations do not address transfer of controlled substance prescriptions — whether paper or electronic — between pharmacies for the initial filling of the prescription.

article thumbnail

The social media problem for healthcare

World of DTC Marketing

From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. I believe too many are making treatment decisions because they don’t have a close relationship with their doctors; even if one person makes a wrong decision, that is one person too many.

Branding 224